tiprankstipranks
Advertisement
Advertisement

Partners Group Strengthens Health & Life Private Equity Arm With Senior Co-Head Hire

Story Highlights
  • Partners Group has named veteran healthcare investor Pete Zippelius Co-Head of its Private Equity Health & Life vertical, expanding leadership for a 40-strong global team.
  • The appointment, alongside recent sector co-head hires, reinforces Partners Group’s strategy to deepen thematic private equity investing and sharpen its edge in healthcare and life sciences.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Partners Group Strengthens Health & Life Private Equity Arm With Senior Co-Head Hire

Meet Samuel – Your Personal Investing Prophet

Partners Group Holding AG ( (CH:PGHN) ) has provided an announcement.

Partners Group, a leading global private markets firm with substantial exposure to healthcare and life sciences, has expanded its sector-specialist leadership as part of a strategy to deepen thematic investing. The company’s Health & Life vertical, which has already deployed about USD 13.2 billion across healthcare services, life sciences, medical technology, and related areas, sits within a broader private equity platform managing USD 86 billion.

The firm has appointed veteran healthcare investor Pete Zippelius as Co-Head of its Private Equity Health & Life vertical, based at its U.S. headquarters from September 2026, to co-lead the 40-strong global team alongside existing co-head Benjamin Breier. Zippelius, who brings over two decades of private equity and investment banking experience and has led USD 8 billion of healthcare and life sciences deals, is expected to drive new investments and portfolio value-creation initiatives, reinforcing Partners Group’s push to capitalize on demographic, innovation, and healthcare system trends.

His hire follows recent senior appointments in technology and goods & products, underlining an ongoing build-out of sector leadership aimed at scaling the firm’s global private equity franchise. For investors and portfolio companies, the move signals a continued emphasis on operationally intensive ownership, more specialized deal sourcing, and a stronger competitive position in a still-active healthcare and life sciences investment landscape.

The most recent analyst rating on (CH:PGHN) stock is a Buy with a CHF920.00 price target. To see the full list of analyst forecasts on Partners Group Holding AG stock, see the CH:PGHN Stock Forecast page.

More about Partners Group Holding AG

Partners Group is one of the largest global private markets investment firms, managing over USD 185 billion in assets across private equity, private credit, infrastructure, real estate, royalties, and special opportunities. Headquartered in Switzerland with a major presence in Colorado, the firm focuses on operationally oriented, thematic investing to build market-leading businesses for its global client base.

The group’s private equity arm manages USD 86 billion and is organized into sector-focused verticals, including Health & Life, Technology, and Goods & Products. With around 2,000 professionals worldwide, Partners Group targets long-term value creation through active ownership and has a significant track record in healthcare, life sciences, and related subsectors.

Average Trading Volume: 115,227

Technical Sentiment Signal: Sell

Current Market Cap: CHF21.67B

For a thorough assessment of PGHN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1